Validation of the Artificial Intelligence Subsystem of the DDART Medical Device for the Automated Detection of Lesions Compatible With Glaucoma in a Random Sample of Retinal Fundus Photographs
1 other identifier
observational
2,000
1 country
1
Brief Summary
Primary Objective To validate the artificial intelligence subsystem of the DDART medical device for the automated detection of lesions compatible with glaucoma in a random sample of retinal fundus photographs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 21, 2026
CompletedFirst Submitted
Initial submission to the registry
August 6, 2026
CompletedFirst Posted
Study publicly available on registry
August 11, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 19, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 19, 2027
August 11, 2026
April 1, 2026
12 months
August 6, 2026
August 6, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Validation of the sensitivity and specificity of the artificial intelligence subsystem for AMD detection
1 year
Validation of the sensitivity and specificity of the artificial intelligence subsystem for diabetic retinopathy detection
1 year
Interventions
Color retinal fundus photographs will be acquired from: Digital non-mydriatic fundus cameras.
Eligibility Criteria
Participants that are able to provide consent for their fundus photograph to be recorded
You may qualify if:
- Age ≥18 years. Availability of a high-resolution color fundus photograph. Confirmed diagnosis established by a specialist.
You may not qualify if:
- Poor-quality images. Coexisting ocular diseases that interfere with image interpretation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital of Alexandroupolis
Alexandroupoli, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Democritus University of Thrace
Study Record Dates
First Submitted
August 6, 2026
First Posted
August 11, 2026
Study Start
April 21, 2026
Primary Completion (Estimated)
April 19, 2027
Study Completion (Estimated)
April 19, 2027
Last Updated
August 11, 2026
Record last verified: 2026-04